New Drug Evaluations

Document	Type	Published
Clascoterone for the treatment of acne vulgaris	New Drug Evaluations	December 2025
Estradiol / progesterone (Bijuve®) for hormone replacement therapy in postmenopausal women	New Drug Evaluations	May 2022
Estradiol spray for the treatment of menopausal symptoms	New Drug Evaluations	February 2022
Fast acting insulin lispro for the treatment of diabetes mellitus	New Drug Evaluations	February 2021
Oral semaglutide for the treatment of type 2 diabetes mellitus	New Drug Evaluations	October 2020
Brolucizumab for wet age-related macular degeneration	New Drug Evaluations	September 2020
Levodopa inhalation powder for episodic motor fluctuations in Parkinson’s disease	New Drug Evaluations	February 2020
Naldemedine for the treatment of opioid induced constipation	New Drug Evaluations	November 2019
Pentosan for the treatment of bladder pain syndrome	New Drug Evaluations	October 2019
Insulin glargine plus lixisenatide (Suliqua) for the treatment of T2DM	New Drug Evaluations	August 2019